MTI Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.mtibiotech.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
Phase 1
Not yet recruiting
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- Interventions
- Other: Placebo
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- MTI Biotech Inc
- Target Recruit Count
- 48
- Registration Number
- NCT06432166
- Locations
- 🇺🇸
Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States
News
No news found